Cyclacel Pharmaceuticals is a biopharmaceutical company that focuses on developing drugs for cancer and other diseases. They are currently undergoing clinical trials for several treatments, including fadraciclib and CYC140 for solid tumors and advanced leukemias. The company has collaborations with the University of Texas MD Anderson Cancer Center to test treatments for hematological malignancies.